Dihydroboldenone vs Testosterone Undecanoate
A side-by-side research comparison of Dihydroboldenone and Testosterone Undecanoate across mechanism, dosing, half-life, benefits, side effects and research status.
Comparison table
| Attribute | Dihydroboldenone | Testosterone Undecanoate |
|---|---|---|
| Full name | Dihydroboldenone (1-Testosterone / DHB) | Testosterone Undecanoate (Ultra-Long Ester) |
| Category | Anabolic Steroids | Anabolic Steroids |
| Status | Not medically approved (controlled substance) | FDA-approved drug (controlled substance) |
| Mechanism | DHB is boldenone with the double bond reduced, giving a highly anabolic, non-aromatizing steroid that does not convert to estrogen or DHT. It has strong androgen-receptor binding and promotes dry, lean gains. | The large undecanoate ester dramatically slows release, giving weeks-long duration from a single injection. Oral undecanoate is absorbed via the lymphatic system, partly bypassing first-pass liver metabolism. |
| Molecular weight | 288.4 Da (base) | 456.7 Da |
| Half-life | Varies by ester | ~20-34 days (injection depot) |
| Bioavailability | Intramuscular injection | Deep IM injection or oral (lymphatic absorption) |
| Typical dose | Lean-gain cycles (non-medical) | Injection every ~10-14 weeks (medical); oral 2x daily with food |
| Frequency | Per ester | Infrequent (injection) or twice daily (oral) |
| Route | Intramuscular injection | Deep intramuscular injection or oral |
Dihydroboldenone reported benefits
- Strong lean mass gains
- No estrogen conversion
- No DHT conversion
- Dry, hard appearance
Testosterone Undecanoate reported benefits
- Very infrequent injections (convenience)
- Stable long-term testosterone (medical)
- Oral option avoids most liver toxicity
- Restores testosterone in deficiency
Related comparisons
Research and educational reference only. Not medical advice.